Implementation strategy for complete pathogen reduction technology treated apheresis platelet inventory. Issue 10 (2nd September 2022)

• Record Type: Journal Article
• Authors: Shu, Elaine; Dela Cruz Batilo, Concepcion; Sussmann, Harry; Owen, Bethany; Belanger, Geoffrey A.; Pandey, Suchitra; Pham, Tho D.
• Is Part Of: Transfusion. Volume 62:Issue 10(2022)
• Page Start: 2108
• Page End: 2116
• Publication Date: 2022-09-02
• Subjects: platelet transfusion -- statistics -- study design; Hematology -- Periodicals; Blood -- Transfusion -- Periodicals; Blood Group Antigens -- Periodicals; Blood Preservation -- Periodicals; Blood Transfusion -- Periodicals; 615
• DOI: 10.1111/trf.17081
• Languages: English
• ISSNs: 0041-1132

Abstract

Abstract: Background: Bacterial contamination in platelets remain a major public health concern, which prompted the US Food and Drug Administration guidance for bacterial contamination mitigation. Pathogen reduction technology (PRT) is one mitigation strategy that has shown success in Europe over the last decade. Therefore, our center sought to transition from a dual system of bacterial culturing (BacT) and PRT to full PRT. Methods: A 1 month pilot study was conducted to simulate 100% PRT conditions. Our center also collected baseline data on key platelet production metrics in the 4 months prior to 100% PRT and compared it to the 4 months post‐implementation. Results: The pilot study showed no statistical differences in split rate, proportion of low‐yield products, or proportion of single, double, and triple collections. The only observed difference was an 11 min increase in the average duration of double collections. Our baseline versus post‐implementation monitoring showed no difference in split rate, discard rate, percentage of low‐yield units, and average yield of low yield units. Statistical differences were detected in the proportion of single, double, and triple collections, as well as the average yield of full dose products. Roughly 20% of our inventory consisted of low‐yield products. Discussion: With suitable mitigation strategies, transitioning to a full PRT inventory may result in higher net margins while not adversely affecting overall platelet production. A pilot study is a good way to project potential effects of switching from a dual BacT and PRT inventory to full PRT, and can be adopted by other centers aiming to make the transition.